Aflac Q3 Adjusted EPS $2.43; Japan Reinsurance Frees ~$1B, 2026 Outlook Raised
AFL sits 18% above its 52-week low of $105.76.
Summary
Aflac's Q3 adjusted EPS slipped 2.4% to $2.43 while GAAP net earnings fell 81.5% on $1.1 billion of portfolio repositioning losses. The company ceded ~¥500 billion of Japan cancer reserves to its Bermuda reinsurer, expects ~$1 billion of capital release, and raised its 2026 Japan margin outlook.
Key Events · Earnings and Guidance · AFL
-
Q3 Adjusted EPS $2.43, Down 2.4%
Adjusted earnings were $1.2 billion versus $1.3 billion a year ago; GAAP net earnings fell 81.5% to $303 million, or $0.61 per diluted share, driven by $1.1 billion of net investment losses from strategic portfolio repositioning.
-
Japan Reinsurance Frees ~$1 Billion
Aflac Japan ceded approximately ¥500 billion of FSA-basis reserves on cancer policies to Aflac Re Bermuda; management estimates the transaction will release roughly $1 billion of capital available for redeployment over time.
-
2026 Outlook Raised for Japan and U.S.
Japan pretax profit margin guidance lifted to 35%-38%, with the benefit ratio now slightly below the 60%-63% range; U.S. pretax margin expected above 17%-20% and benefit ratio below 48%-52%.
-
Fourth Quarter Dividend Declared at $0.61
Payable December 1, 2026 to shareholders of record November 18, 2026, marking 44 consecutive years of dividend increases; Q3 capital return totaled $1.1 billion, including $804 million of buybacks.
Analysis · AFL · Finance
Adjusted EPS fell 2.4% to $2.43 and net earnings collapsed 81.5% to $303 million, but the GAAP drop is almost entirely a $1.1 billion net investment loss from repositioning the investment portfolio, not operating deterioration. The more consequential news is buried in the CFO commentary: Aflac Japan ceded roughly ¥500 billion of cancer-insurance reserves to Aflac Re Bermuda, which management expects to release about $1 billion of capital for redeployment over time, and the company raised its 2026 Japan pretax margin outlook to 35%-38%. Against a stock trading near its 52-week high, the quarter supports the thesis rather than challenging it — adjusted ROE excluding FX was 23.7%, capital ratios remain strong (ESR 225%, combined RBC above 575%), and $1.1 billion went back to shareholders.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AFL was trading at $125.27 on NYSE in the Finance sector, with a market capitalization of approximately $62.8B. The 52-week trading range was $105.76 to $130.22. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.